Patents by Inventor Kentaro Takamura
Kentaro Takamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240115652Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: ApplicationFiled: September 13, 2023Publication date: April 11, 2024Inventors: Kentaro Takamura, Satoshi Gojo, Satoru Kobayashi
-
Publication number: 20240069761Abstract: A storage system includes a storage controller and a plurality of storage drives. The storage controller holds power management information for managing power supplied to the storage system and power consumption of an operating mounted device of the storage system, and definition information for defining a relationship between power states and power consumption of the plurality of storage drives. The storage controller determines a power budget that can be supplied to the plurality of storage drives, based on the power management information according to a change in a configuration of the storage system, and determines a power state of each of the plurality of storage drives based on the power budget and the definition information.Type: ApplicationFiled: March 7, 2023Publication date: February 29, 2024Applicant: Hitachi, Ltd.Inventors: Naoya OKADA, Kentaro SHIMADA, Yuki KOTAKE, Yukiyoshi TAKAMURA
-
Patent number: 11801281Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: GrantFiled: January 4, 2022Date of Patent: October 31, 2023Assignee: 3-D Matrix, Ltd.Inventors: Kentaro Takamura, Satoshi Gojo, Satoru Kobayashi
-
Publication number: 20220193184Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: ApplicationFiled: January 4, 2022Publication date: June 23, 2022Inventors: Kentaro Takamura, Satoshi Gojo, Satoru Kobayashi
-
Publication number: 20220168462Abstract: Systems and methods of blocking a biological vessel 2 are provided. The systems and methods may comprise introducing to the vessel an amphiphilic peptide. The peptide may comprise at least thirteen amino acids that may alternate between a hydrophobic amino acid and a hydrophilic amino acid. The peptide may form a beta- sheet spontaneously in an aqueous solution in the presence of a cation.Type: ApplicationFiled: November 24, 2021Publication date: June 2, 2022Applicant: 3-D Matrix, Ltd.Inventors: Satoru Kobayashi, Kentaro Takamura
-
Publication number: 20200222496Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: ApplicationFiled: January 15, 2020Publication date: July 16, 2020Inventors: Kentaro Takamura, Satoshi Gojo, Satoru Kobayashi
-
Patent number: 10596225Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: GrantFiled: October 4, 2013Date of Patent: March 24, 2020Assignee: 3-D Matrix, Ltd.Inventors: Kentaro Takamura, Satoshi Gojo, Satoru Kobayashi
-
Patent number: 10576123Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: GrantFiled: October 6, 2009Date of Patent: March 3, 2020Assignee: 3-D Matrix, Ltd.Inventors: Kentaro Takamura, Satoshi Gojo, Satoru Kobayashi
-
Publication number: 20160287744Abstract: Systems and methods of blocking a biological vessel are provided. The systems and methods may comprise introducing to the vessel an amphiphilic peptide. The peptide may comprise at least thirteen amino acids that may alternate between a hydrophobic amino acid and a hydrophilic amino acid. The peptide may form a beta-sheet spontaneously in an aqueous solution in the presence of a cation.Type: ApplicationFiled: November 14, 2013Publication date: October 6, 2016Inventors: Satoru Kobayashi, Kentaro Takamura
-
Publication number: 20150105336Abstract: Provided is a mucosa-elevating agent containing 0.1% to 1.0% of a peptide, wherein the peptide is an amphipathic protein having 8 to 200 amino acid residues in which hydrophilic amino acids and hydrophobic amino acids are alternately bonded, and is a self-assembling peptide that exhibits a ? structure in an aqueous solution at physiological pH and/or in the presence of cations.Type: ApplicationFiled: March 8, 2013Publication date: April 16, 2015Inventors: Kentaro Takamura, Satoru Kobayashi, Noriaki Matsuda
-
Publication number: 20140329914Abstract: Provided are compounds and methods useful for sealing air leaks in the thoracic cavity. Compounds and compositions of the invention comprise certain amphiphilic peptides, 8-200 amino acid residues long, that self-assemble spontaneously to form a gel in the presence of physiological pH and/or in the presence of a cation. In one embodiment, the peptide comprises a repeated sequence arginine-alanine-aspartic acid-alanine (RADA). Methods of the invention include a method of occluding a pulmonary air leak in a subject, comprising applying a compound of the invention to the site of a pulmonary air leak. The compounds and methods of the invention can be combined with other agents useful to treat cancer, inflammation, or infection.Type: ApplicationFiled: August 31, 2012Publication date: November 6, 2014Applicant: 3-D Matrix Ltd.Inventors: Satoru Kobayashi, Satoshi Okada, Kentaro Takamura
-
Publication number: 20140038909Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: ApplicationFiled: October 4, 2013Publication date: February 6, 2014Applicant: 3-D MATRIX, LTD.Inventors: Kentaro TAKAMURA, Satoshi GOJO, Satoru KOBAYASHI
-
Publication number: 20130296239Abstract: The invention relates to a material for wound healing and skin reconstruction containing a peptide, wherein the peptide is a self-assembling peptide which is an amphiphilic peptide having 8 to 200 amino acid residues with periodic repeats of alternating hydrophilic amino acids and hydrophobic amino acids, and forms a stable ?-sheet structure in an aqueous solution in the presence of a monovalent ion. The material for wound healing and skin reconstruction of the present invention is capable of healing a wound area of mammals quicker than spontaneous recovery without leaving any scars, wherein the material has no potential risk of infectious disease such as virus transmission.Type: ApplicationFiled: December 21, 2012Publication date: November 7, 2013Inventors: Kentaro Takamura, Jiro Takei
-
Publication number: 20110201541Abstract: There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a ?-structure in aqueous solution in the presence of physiological pH and/or a cation.Type: ApplicationFiled: October 6, 2009Publication date: August 18, 2011Applicant: 3-D MATRIX, LTD.Inventors: Kentaro Takamura, Satoshi Gojo, Satoru Kobayashi
-
Publication number: 20110002880Abstract: The invention relates to a material for wound healing and skin reconstruction containing a peptide, wherein the peptide is a self-assembling peptide which is an amphiphilic peptide having 8 to 200 amino acid residues with periodic repeats of alternating hydrophilic amino acids and hydrophobic amino acids, and forms a stable ?-sheet structure in an aqueous solution in the presence of a monovalent ion. The material for wound healing and skin reconstruction of the present invention is capable of healing a wound area of mammals quicker than spontaneous recovery without leaving any scars, wherein the material has no potential risk of infectious disease such as virus transmission.Type: ApplicationFiled: December 4, 2008Publication date: January 6, 2011Applicant: 3-D MATRIX, LTD.Inventors: Kentaro Takamura, Jiro Takei